BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28577832)

  • 1. Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Murray LJ; Dawson LA
    Semin Radiat Oncol; 2017 Jul; 27(3):247-255. PubMed ID: 28577832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of stereotactic body radiation therapy for hepatocellular carcinoma.
    Kimura T; Doi Y; Takahashi S; Kubo K; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Murakami Y; Kenjo M; Nagata Y
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):271-279. PubMed ID: 32223683
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
    Choi SH; Seong J
    Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
    McPartlin AJ; Dawson LA
    Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
    Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy for early hepatocellular carcinoma: a retrospective analysis of the South Australian experience.
    Wigg AJ; Narayana SK; Le H; Iankov I; Chinnaratha MA; Tse E; Chen JW; Gowda R
    ANZ J Surg; 2019 Sep; 89(9):1138-1143. PubMed ID: 30983104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
    Schaub SK; Hartvigson PE; Lock MI; Høyer M; Brunner TB; Cardenes HR; Dawson LA; Kim EY; Mayr NA; Lo SS; Apisarnthanarax S
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818790217. PubMed ID: 30068240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.
    Jackson WC; Suresh K; Maurino C; Feng M; Cuneo KC; Ten Haken RK; Lawrence TS; Schipper MJ; Owen D
    Radiother Oncol; 2019 Dec; 141():101-107. PubMed ID: 31431377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
    Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
    BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
    Mendiratta-Lala M; Masch W; Shankar PR; Hartman HE; Davenport MS; Schipper MJ; Maurino C; Cuneo KC; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):169-179. PubMed ID: 30213751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.
    Moon DH; Wang AZ; Tepper JE
    Radiother Oncol; 2018 Mar; 126(3):527-533. PubMed ID: 29366521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Soni PD; Palta M
    Dig Dis Sci; 2019 Apr; 64(4):1008-1015. PubMed ID: 30868409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of stereotactic body radiation therapy for hepatocellular carcinoma.
    Sanuki N; Takeda A; Kunieda E
    World J Gastroenterol; 2014 Mar; 20(12):3100-11. PubMed ID: 24696597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
    Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK
    Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.
    Meng M; Wang H; Zeng X; Zhao L; Yuan Z; Wang P; Hao X
    Drug Discov Ther; 2015 Oct; 9(5):372-9. PubMed ID: 26632546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Rim CH; Kim HJ; Seong J
    Radiother Oncol; 2019 Feb; 131():135-144. PubMed ID: 30773180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
    Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformal and stereotactic radiotherapy in hepatocellular carcinoma.
    Scorsetti M; Bignardi M
    Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines?
    Xu MJ; Feng M
    Semin Liver Dis; 2019 Feb; 39(1):43-52. PubMed ID: 30536291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.